A highly sensitive LC-MS/MS method capable of simultaneously quantitating celiprolol and atenolol in human plasma for a cassette cold-microdosing study

Journal of Separation Science

Volumn 34, Issue 13, 2011, Pages 1590-1598

  Minamide, Yoshiyuki ^a,b   Osawa, Yukio ^a   Nishida, Hiroshi ^a   Igarashi, Harue ^a   Kudoh, Shinobu ^a  

^a SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^b NONE   (Japan)

Author keywords

LC MS; Microdosing; MS; Solid phase extraction; blocker

Indexed keywords

COLUMN CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; PLASMA (HUMAN); PROJECTILES;

LC-MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MICRODOSING; REVERSED PHASE CHROMATOGRAPHY; SELECTED REACTION MONITORING; SOLID-PHASE EXTRACTION; STRONG CATION EXCHANGES; TRIPLE-QUADRUPOLE MASS SPECTROMETER;

EXTRACTION;

ATENOLOL; CELIPROLOL; METOPROLOL;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ISOLATION; ELUTION; FLOW RATE; HUMAN; HUMAN TISSUE; ION EXCHANGE CHROMATOGRAPHY; IONIZATION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 79959389015     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.201100089     Document Type: Article

References (25)

1. US Department of Health and Human Services, Food and Drug Administration. Guidance for Industry, Investigators, and Reviewers-Exploratory IND Studies, 2006.
2. European Agency for the Evaluation of Medicines for Human Use (EMEA), Position Paper on the Nonclinical Safety Studies to Support Clinical Trials with a Single Microdose, CPMP/SWP2599/0, 2003.
3. Maeda, K., Sugiyama, Y., Jpn. J. Clin. Pharmacol. Ther. 2010, 41, 27-34.
4. Lappin, G., Kuhnz, W., Jochemsen, R., Kneer, J., Chaudhary, A., Oosterhuis, B., Drijfhout, W. J., Rowland, M., Garner, R. C., Clin. Pharmacol. Ther. 2006, 80, 203-215.
5. Sarapa, N., Hsyu, P. H., Lappin, G., Garner, R. C., J. Clin. Pharmacol. 2005, 45, 1198-1205.
6. Barker, J., Garner, R. C., Rapid Commun. Mass Spectrom. 1999, 13, 285-293.
7. Young, G., Ellis, W., Ayrton, J., Hussey, E., Adamkiewicz, B., Xenobiotica 2001, 31, 619-632.
8. Vuong, L. T., Ruckle, J. L., Blood, A. B., Reid, M. J., Wasnich, R. D., Synal, H. A., Dueker, S. R., J. Pharm. Sci. 2008, 97, 2833-2843.
9. Minamimoto, R., Hamabe, Y., Miyaoka, T., Hara, T., Yoshida, K., Oka, T., Inoue, T., Ann. Nucl. Med. 2008, 22, 883-889.
10. Vogel, J. S., Turtletaub, K. W., Finkel, R., Nelson, D. E., Anal. Chem. 1995, 67, 353A-359A.
11. Sandhu, P., Vogel, J. S., Rose, M. J., Ubick, E. A., Brunner, J. E., Wallace, M. A., Adelsberger, J. K., Baker, M. P., Henderson, P. T., Pearson, P. G., Baillie, T. A., Drug Metab. Dispos. 2004, 32, 1254-1259.
12. Balani, S. K., Nagaraja, N. V., Qian, M. G., Costa, A. O., Daniels, J. S., Yang, H., Shimoga, P. R., Wu, J. T., Gan, L. S., Lee, F. W., Miwa, G. T., Drug Metab. Dispos. 2006, 34, 384-388.
13. Ni, J., Ouyang, H., Aiello, M., Seto, C., Borbridge, L., Sakuma, T., Ellis, R., Welty, D., Acheampong, A., Pharm. Res. 2008, 25, 1572-1582.
14. Yamane, N., Tozuka, Z., Sugiyama, Y., Tanimoto, T., Yamazaki, A., Kumagai, Y., J. Chromatogr. B 2007, 858, 118-128.
15. Ram, C. V. S., Am. J. Cardiol. 2010, 106, 1819-1825.
16. Wiysonge, C. S. U., Bradley, H. A., Mayosi, B. M., Maroney, R. T., Mbewu, A., Opie, L., Volmink, J., Cochrane Database Syst. Rev. 2007, Art. No.: CD002003.
17. Wright, J. M., Musini, V. M., Cochrane Database Syst. Rev. 2009, Art. No.: CD001841.
18. Kataoka, H., Narimatsu, S., Lord, H. L., Pawliszyn, J., Anal. Chem. 1999, 71, 4237-4244.
19. Kolmonen, M., Leinonen, A., Pelander, A., Ojanperä, I., Anal. Chim. Acta 2007, 585, 94-102.
20. Maurer, H. H., Tenberken, O., Kratzsch, C., Weber, A. A., Peters, F. T., J. Chromatogr. A 2004, 1058, 169-181.
21. Gros, M., Pizzolato, T. M., Petrović, M., López de Alda, M. J., Barceló, D., J. Chromatogr. A 2008, 1189, 374-384.
22. Lu, M., Zhang, L., Qiu, B., Feng, Q., Xia, S., Chen, G., J. Chromatogr. A 2008, 1193, 156-163.
23. Johnson, R. D., Lewis, R. J., Forensic Sci. Int. 2006, 156, 106-117.
24. US Department of Health and Human Services, Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation, 2001.
25. Marchi, I., Rudaz, S., Veuthey, J.-L., J. Pharm. Biomed. Anal. 2008, 49, 459-467.